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ABSTRACT Helminths have coevolved with their hosts, resulting in the development
of specialized host immune mechanisms and parasite-speciﬁc regulatory products. Iden-
tiﬁcation of new pathways that regulate helminth infection could provide a better un-
derstanding of host-helminth interaction and may identify new therapeutic targets for
helminth infection. Here we identify the endocannabinoid system as a new mechanism
that inﬂuences host immunity to helminths. Endocannabinoids are lipid-derived signal-
ing molecules that control important physiologic processes, such as feeding behavior
and metabolism. Following murine infection with Nippostrongylus brasiliensis, an intesti-
nal nematode with a life cycle similar to that of hookworms, we observed increased lev-
els of endocannabinoids (2-arachidonoylglycerol [2-AG] or anandamide [AEA]) and the
endocannabinoid-like molecule oleoylethanolamine (OEA) in infected lung and intestine.
To investigate endocannabinoid function in helminth infection, we employed pharmaco-
logical inhibitors of cannabinoid subtype receptors 1 and 2 (CB1R and CB2R). Compared
to ﬁndings for vehicle-treated mice, inhibition of CB1R but not CB2R resulted in in-
creased N. brasiliensis worm burden and egg output, associated with signiﬁcantly de-
creased expression of the T helper type 2 cytokine interleukin 5 (IL-5) in intestinal tissue
and splenocyte cultures. Strikingly, bioinformatic analysis of genomic and transcriptome
sequencing (RNA-seq) data sets identiﬁed putative genes encoding endocannabinoid
biosynthetic and degradative enzymes in many parasitic nematodes. To test the novel
hypothesis that helminth parasites produce their own endocannabinoids, we measured
endocannabinoid levels in N. brasiliensis by mass spectrometry and quantitative PCR and
found that N. brasiliensis parasites produced endocannabinoids, especially at the infec-
tious larval stage. To our knowledge, this is the ﬁrst report of helminth- and host-
derived endocannabinoids that promote host immune responses and reduce parasite
burden.
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Parasitic helminths infect an estimated two billion individuals worldwide (1). Al-though helminth infection is not typically fatal, it is associated with a multitude of
pathological conditions, including malnutrition and growth retardation. A majority of
soil-transmitted helminths reside in the gastrointestinal tract, where they can nega-
tively impact the host’s nutritional status by stealing nutrients or preventing nutrient
absorption by damaging or causing inﬂammation of the intestinal tissue (2). Addition-
ally, recent studies have identiﬁed new mechanisms by which helminths impact host
feeding and metabolism (3). Gastrointestinal helminth infection was reported to de-
crease food intake (4) and was beneﬁcial in mice fed a high-fat diet, in which it
improved glucose metabolism and reduced adiposity (5, 6). This effect was partly
mediated through T helper type 2 (Th2) cytokine-activated M2 macrophages in the
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adipose tissue, which have a known beneﬁcial effect on metabolic homeostasis (7). In
the intestine, helminth infection induced a Th2 cytokine-dependent expansion of tuft
cells, which express taste receptors, and cholecystokinin (CCK)-positive enteroendo-
crine cells, which secrete hormones that regulate feeding behavior (8). Overall, these
ﬁndings support a multifactorial relationship between helminth and host immune
response that affects host feeding behavior and metabolism. Identiﬁcation of new
helminth or host-derived factors that regulate this process, and how they affect host
health and helminth killing, could provide a better understanding of the pathological
or beneﬁcial effects of helminth infection that could be exploited therapeutically.
Among the many host-derived molecules that affect feeding and metabolism,
endocannabinoids are an important class of lipid molecules that regulate these phys-
iological processes (9, 10). Endocannabinoids are the body’s natural cannabis-like
molecules that signal through cannabinoid receptors, which are highly expressed on
neurons (11). Unsurprisingly, a highly recognized function of endocannabinoids is
promoting neurally mediated behaviors such as food intake and reward (9). Endocan-
nabinoids, however, are generated throughout the body, and cannabinoid receptors
are present on extraneuronal cells, including intestinal epithelial cells and immune cells
(12–14). Signaling by the endocannabinoids, 2-arachidonoylglycerol (2-AG) and anan-
damide (AEA), through cannabinoid receptors on intestinal cells impacts feeding
behavior (15, 16), while signaling on immune cells can promote anti-inﬂammatory
pathways (17). Despite functional effects on intestinal physiology and immune re-
sponses, no studies reported to date have investigated the role of endocannabinoids in
parasite infection.
In this study, we investigated the expression and function of endocannabinoids in
murine infection with Nippostrongylus brasiliensis, a rodent nematode parasite that has a life
cycle similar to that of human hookworms (18). We show that N. brasiliensis infection
signiﬁcantly induces the biosynthesis of endocannabinoids and endocannabinoid-like mol-
ecules in the infected lung and intestine. We also performed functional assays to measure
endocannabinoid biosynthetic and degradative enzyme activity in infected jejunal tissue,
and we observed signiﬁcantly increased endocannabinoid synthetic but not degradative
enzyme activity. Endocannabinoid levels were negatively correlated with early infection-
induced weight loss, associated with reduced food intake, and N. brasiliensis egg output,
suggesting that endocannabinoids are associated with improved host immunity. To test
this hypothesis, we employed validated peripheral pharmacological inhibitors of the can-
nabinoid subtype 1 receptor (CB1R) and CB2R, AM6545 and AM630, respectively, which act
peripherally and do not cross the blood-brain barrier (16, 19). Pharmacological inhibition of
CB1R, but not CB2R, signiﬁcantly increased N. brasiliensis worm burdens and fecal egg
output. Increased parasite burden was associated with reductions in Th2 cytokines (inter-
leukin 5 [IL-5] and IL-4) but not in the Th1 cytokine gamma interferon (IFN-), suggesting
that N. brasiliensis-induced endocannabinoid signaling through CB1R was important for
optimal host Th2 immune responses. Strikingly, bioinformatic analyses of the genomes and
transcriptome sequencing (RNA-seq) data sets from N. brasiliensis and other parasitic
nematodes, including the hookworms Ancylostoma ceylanicum and Necator americanus,
revealed putative genes encoding endocannabinoid synthetic and degradative enzymes.
We validated the bioinformatic predictions for N. brasiliensis by quantitative real-time PCR
and mass spectrometry (MS) and showed that N. brasiliensis produces endocannabinoids at
all life cycle stages. Taken together, these studies show for the ﬁrst time the production of
endocannabinoids by parasitic helminths and suggest that helminth infection-induced
endocannabinoids functionally inﬂuence the host immune response and parasite burden.
These ﬁndings support a new area of investigation into the function of the endocannabi-
noid system in infectious diseases.
RESULTS
Nippostrongylus brasiliensis infection induces lung and intestinal endocannabi-
noid production. Endocannabinoids are lipid signaling mediators that affect a variety
of behaviors (e.g., feeding and memory) and metabolic processes (e.g., glucose ho-
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meostasis) (see Fig. S1 in the supplemental material) (9). Additionally, endocannabi-
noids can regulate the immune response and dampen inﬂammation (20). Despite
reported immunoregulatory function, however, whether endocannabinoids are gener-
ated in parasite infection and the functional consequence for the host or pathogen are
unknown. N. brasiliensis infects the small intestine of mice and has been shown to affect
food intake and metabolism (3–5). Given that endocannabinoids and endocannabinoid
receptors are expressed in the intestine, we hypothesized that N. brasiliensis infection
may affect endocannabinoid signaling. Similar to the hookworm life cycle, N. brasiliensis
infects both the lung and the intestine as part of its life cycle and feeds on host blood
(21). We therefore measured tissue and circulating endocannabinoid levels in naive and
N. brasiliensis-infected mice at days 2 and 7 postinfection, when the parasites had
infected the lung and jejunum, respectively. We observed a modest but signiﬁcant
increase in 2-AG and AEA in N. brasiliensis-infected lung tissue and a trend toward
increased levels of endocannabinoid-like molecule oleoylethanolamine (OEA) (Fig. 1A).
Strikingly, 2-AG levels in jejunal tissue were almost 10-fold higher than in the lung, and
we observed a 2-fold increase following N. brasiliensis infection (Fig. 1B). AEA and
OEA, both of which regulate feeding and are anti-inﬂammatory (15, 22, 23), were also
signiﬁcantly elevated in the jejunum in response to N. brasiliensis infection (Fig. 1B). In
contrast, circulating endocannabinoid levels in the plasma were unchanged following
N. brasiliensis infection (Fig. 1C), suggesting that N. brasiliensis-induced endocannabi-
noids were restricted to the tissue infection site. Given that the 2-AG levels were highest
in the infected jejunum, we next evaluated the activity of the biosynthetic and
degradative enzymes responsible for 2-AG metabolism in jejunal epithelium of infected
versus naive mice. Speciﬁcally, we measured the enzymatic activities of diacylglycerol
lipase (DGL; biosynthetic) and monoacylglycerol lipase (MGL; degradative) by func-
tional enzyme assays (15). We found signiﬁcant increases in the activity of DGL in the
jejunal tissue of infected mice compared to noninfected mice (Fig. 1D, left), which
suggests that levels of 2-AG in jejunum are elevated in infected mice by a mechanism
that includes increases in jejunal DGL-mediated 2-AG biosynthesis. In contrast, we did
not observe any changes in enzymatic activity of MGL (Fig. 1D, right). Endocannabi-
FIG 1 N. brasiliensis infection induces endocannabinoid production and cannabinoid receptor expres-
sion. C57BL/6 mice were left naive or infected for 2 or 7 days with 500 N. brasiliensis L3 worms. 2-AG, AEA,
and OEA levels in the lung at day 2 (A), jejunum at day 7 (B), and plasma at day 2 and day 7 (C). (D) 2-AG
biosynthetic (DGL, left) and degradative (MGL, right) enzyme activities were measured in jejunal tissue
from naive or day 7 infected mice. (E) N. brasiliensis infection-induced Cnr1 and Cnr2 mRNA in the jejunal
tissue at day 7 was quantiﬁed as fold induction over naive after normalization with the 18S rRNA
housekeeping gene. Data are presented as means  SEM (n  4 to 6/group) and are representative of
results from four experiments.
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noids signal through the G protein-coupled cannabinoid receptors subtype 1 and 2;
therefore, we measured the cannabinoid receptor coding genes Cnr1 and Cnr2 mRNA
by quantitative PCR of the jejunal tissue. N. brasiliensis infection induced signiﬁcant
increases in both Cnr1 and Cnr2 (Fig. 1E). Collectively, these data demonstrate that N.
brasiliensis infection increases endocannabinoid levels locally in the infected lung and
intestinal tissue and promotes intestinal endocannabinoid receptor expression, sug-
gesting that the endocannabinoid system is induced in helminth infection.
Intestinal endocannabinoids are negatively correlated with Nippostrongylus
brasiliensis infection-induced weight loss and parasite egg burdens. We examined
if N. brasiliensis-induced endocannabinoids were associated with health outcomes for
the host or parasite by correlative analyses between endocannabinoid levels and
infection-induced weight loss or parasite egg burdens. N. brasiliensis infectious larval
stage 3 (L3) helminths migrate to the lung, where they develop into L4, followed by
infection of the small intestine, where they develop into adults and produce eggs (Fig.
2A and B). At an infectious dose of 500 L3 helminths, N. brasiliensis infection of the lung,
which occurs between days 1 and 3 postinfection, causes lung hemorrhaging and
inﬂammation likely due to the physical damage of the worm burrowing through the
lung tissue. During this acute infection of the lung, we observed signiﬁcant weight loss
that was remarkably resolved once the N. brasiliensis parasites were established in the
intestine, at day 6 (Fig. 2A). Consistent with this weight loss, analysis of feeding patterns
in naive and infected mice revealed reduced food intake (P  0.05) and motor activity
(P  0.05) at day 1 postinfection, when the N. brasiliensis parasites had reached the
lung, that was also resolved by day 6 postinfection (Fig. 2C). We also observed a
signiﬁcant positive correlation between N. brasiliensis-induced acute weight loss at day
3 and N. brasiliensis egg burdens at day 7 postinfection (Fig. 2D, left). This correlation
suggests that acute infection-induced weight loss at day 3 may be a good predictor of
subsequent parasite establishment in the intestine. The effect of N. brasiliensis infection
FIG 2 Intestinal endocannabinoid levels are negatively correlated with infection-induced weight loss and fecal egg
burdens. (A) Time course of N. brasiliensis infection-induced weight loss. (B) Compiled data of N. brasiliensis parasite
burdens in lung and small intestine. (C) Food, water intake, and motor activities of naive (N) and N. brasiliensis-infected (INF)
mice were evaluated in a feeding chamber. (D) Correlation analysis between parasite egg burden and weight loss (left) and
jejunal 2-AG (right) was performed. Data are presented as means  SEM and are representative of results from two to four
experiments (n  4 to 6/group).
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on mouse weight changes may be due to lung tissue inﬂammation or changes in
mouse feeding behavior.
Given that endocannabinoids can regulate both these processes, we investigated
correlations between endocannabinoids and N. brasiliensis parasite burdens. We ob-
served that 2-AG intestinal levels from day 7 infected mice were negatively correlated
with early infection-induced weight loss (day 3) and day 7 parasite egg burden (Fig. 2D,
right). To comprehensively deﬁne the relationship between endocannabinoids versus
host and parasite ﬁtness, we performed Spearman correlation analyses across all
experiments (Table 1). We observed a negative correlation between day 7 infected
jejunum 2-AG and OEA and (i) early (day 3) infection-induced weight changes and (ii)
day 7 parasite egg burden. In contrast, we observed a positive correlation between
plasma 2-AG and OEA, weight loss, and parasite egg burden. These data indicate that
high endocannabinoid levels locally in the intestine are associated with reduced early
infection-induced weight loss and decreased parasite egg burden.
Disruption of CB1 receptor but not CB2 receptor signaling increases Nippos-
trongylus brasiliensis egg burden and impairs intestinal IL-5 responses. The endo-
cannabinoids, 2-AG and AEA, both of which were upregulated following N. brasiliensis
infection (Fig. 1), signal through CB1R and CB2R (12). We investigated the function of
endocannabinoid signaling in N. brasiliensis infection by treatment with the peripher-
ally restricted neutral CB1R antagonist AM6545 (24, 25), CB2R antagonist AM630 (19),
and dimethyl sulfoxide (DMSO) as a vehicle control. To rule out potential confounding
effects on parasite establishment in the intestine, mice were treated daily with antag-
onists or vehicle starting at day 4 postinfection, when all N. brasiliensis parasites had
reached the intestine. At this time point, CB1R or CB2R inhibition had no effect on
mouse weight (Fig. 3A). Interestingly, CB1R but not CB2R inhibition led to increased
fecal N. brasiliensis egg output and intestinal N. brasiliensis worm counts (Fig. 3B),
suggesting that CB1R signaling is necessary for optimal N. brasiliensis explusion. We
validated these CB1R inhibitor-mediated differences in N. brasiliensis burdens across
three experimental repeats, using generalized linear models, and found that CB1R
inhibitor treatment led to a 2.21-fold-higher egg burden (P 0.01) and 1.46-fold-higher
worm burden (P  0.01) (Table 2). CB1R inhibition resulted in signiﬁcantly decreased
intestinal levels of the Th2 cytokine IL-5 but not IL-4, IFN-, or IL-10 (Fig. 3C). Further,
in vitro CD3/CD28-activated splenocytes from CB1R inhibitor-treated mice secreted
signiﬁcantly less IL-5, IL-4, and IL-10 than vehicle-treated mice but exhibited no defect
in IFN- secretion (Fig. 3D). This cytokine effect was speciﬁc to CB1R signaling, as
inhibition of CB2R signaling had no signiﬁcant effect. Given that host immunity to N.
brasiliensis is dependent on Th2 cytokines, the CB1R inhibitor-induced decrease in IL-5
and IL-4 may explain the increase in parasite egg burden. Additionally, the signiﬁcant
reduction in IL-10 secretion is consistent with an anti-inﬂammatory function for CBR
signaling (22). These data support the functional link between the endocannabinoid
system and immunity to N. brasiliensis and suggest that CB1R signaling has a beneﬁcial
impact for the host following N. brasiliensis infection by promoting Th2 cytokine
expression and reducing parasite burdens.
TABLE 1 Correlation analysis between endocannabinoids from day 7 N. brasiliensis-
infected mice, day 3 infection-induced weight loss, and day 7 parasite egg burdena
Parameter
Value or statistical signiﬁcance for:
Jejunum eCB Plasma eCB
Weight loss 2-AG AEA OEA 2-AG AEA OEA
Spearman r 0.8154 0.3678 0.7159 0.7688 0.3617 0.7269
P value *** NS ** *** NS **
Egg burden
Spearman r 0.7137 0.4265 0.6593 0.7279 0.1878 0.6127
P value ** NS ** ** NS *
an  17. eCB, endocannabinoids; NS, not signiﬁcant.
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The endocannabinoid system is present in Nippostrongylus brasiliensis and
other parasitic helminths. The endocannabinoid system is conserved in vertebrates
and some invertebrates (26), and endocannabinoid biosynthetic and degradative en-
zymes are expressed in Caenorhabditis elegans (27). However, whether the endocan-
nabinoid system exists in parasitic helminths is unknown. We conducted bioinformatic
FIG 3 Pharmacological inhibition of cannabinoid receptor 1 but not cannabinoid receptor 2 increases
helminth burdens associated with decreased IL-5 expression. C57BL/6 mice were left naive (black) or
infected with N. brasiliensis. At days 4 to 7 postinfection, mice were treated intraperitoneally with
AM6545 (CB1 inhibotor [Inh]; red), AM630 (CB2 inhibitor; gray), or DMSO (VEH; blue). (A) Infection-
induced weight loss was monitored and compared to that in naive mice. (B) Fecal egg burdens (left) and
intestinal worm counts (right) were quantiﬁed in N. brasiliensis-infected mice. (C and D) IL-5, IL-4, IFN-,
and IL-10 were quantiﬁed in day 8 infected (C) intestinal tissue homogenate and (D) supernatant from
72-h anti-CD3/anti-CD28-stimulated splenocytes. Data are presented as means SEM (n 4 to 6/group)
and representative of results from three separate experiments.
TABLE 2 Effect of CBR1 inhibitor on N. brasiliensis egg and worm burden estimated by
linear regression modelsa
CB1 inhibitor effect Effect estimation 95% conﬁdence interval P value
Egg burden 2.21 1.25 to 3.91 0.01
Worm count 1.46 1.29 to 1.64 0.001
an  16 to 18/group.
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analyses of available parasitic nematode genomes for genes involved in the endocan-
nabinoid synthetic and signaling pathway (Table 3). Within the N. brasiliensis genome,
genes encoding synthetic enzymes for the monoacylglycerols, 2-AG and DHAG (dagl),
and the fatty acid ethanolamides, AEA, OEA, and docosahexaenoylethanolamide (DHEA)
(nape), were identiﬁed. We also found orthologs of the fatty acid ethanolamide deg-
radative enzyme fatty acid amide hydrolase (faah-1), the proposed monoacylglycerol
degradative enzymes alpha beta hydroxylases (abhd-12 and abhd-5). Although nema-
todes did not have obvious orthologs of monoacylglycerol lipase (magl), the major
degradative enzyme for 2-AG found in mammals, we identiﬁed a putative nematode
gene encoding the minor 2-AG degradative enzyme, abhd-6 (28). Moreover, the syn-
thetic and degradative endocannabinoid genes were conserved in other nematodes,
including the human hookworms Ancylostoma duodenale and Necator americanus and
human roundworm Ascaris lumbricoides.
Analysis of available RNA-seq data sets revealed the expression of putative genes for
the endocannabinoid pathway in parasitic nematodes of humans (A. ceylanicum, Ascaris
suum, N. americanus, Toxocara canis, and Strongyloides stercoralis), rodents (N. brasil-
iensis and Strongyloides ratti), and even insects (Steinernema carpocapsae) (Fig. 4; see
also Fig. S2 in the supplemental material). Further, these genes were expressed in a
tissue- or stage-speciﬁc manner in some of these parasites. For example, the hookworm
A. ceylanicum, which infects humans and other mammals, showed expression of abhd-5
in all stages sampled but showed highest expression of abhd-5 in the infective L3 stage.
In the human hookworm N. americanus, both nape-1 and abhd-12 were more highly
expressed in L3 larvae than in adult nematodes. Although it was previously thought
that no obvious orthologs of CB1 and CB2 receptors were present in nematodes, a
recent study identiﬁed the neuropeptide receptor NPR-19 as a cannabinoid-like recep-
tor in C. elegans (29–33). We were able to ﬁnd putative orthologs of the cannabinoid-
like receptor NPR-19 in other nematodes, including A. ceylanicum, N. americanus, and
Wuchereria bancrofti (Table 3). However, we were not able to ﬁnd an obvious ortholog
of NPR-19 in N. brasiliensis, though this may be due to the incomplete state of the
available N. brasiliensis genome (N50  33.5 kb; i.e., nearly 30% of the predicted
protein-coding genes are on contigs smaller than 10 kb), rather than the absence of an
NPR-19 ortholog (34, 35).
Nippostrongylus brasiliensis produces endocannabinoids. Given the presence of
genes encoding endocannabinoid synthetic and degradative enzymes in the N. brasil-
iensis genome, we investigated if N. brasiliensis could produce endocannabinoids at any
stage of its life cycle. We isolated infectious N. brasiliensis L3 worms from hatched fecal
cultures, N. brasiliensis L4 worms from day 2 infected lungs, and N. brasiliensis adults
from day 7 infected jejunum, performed thorough washes in phosphate-buffered saline
(PBS), and measured endocannabinoid levels. Although there were no endocannabi-
noids in the control washes, we measured detectable levels of endocannabinoids and
endocannabinoid-like molecules in worm extracts from all life cycle stages (Fig. 5A).
These exhibited identical chromatogram patterns to reference endocannabinoids, AEA
(Fig. 5B) and 2-AG (Fig. 5C), and endocannabinoid-like molecules (see Fig. S3A to C in
TABLE 3 Putative genes in endocannabinoid signaling and degradation identiﬁed in the genomes of N. brasiliensis, human hookworms,
and other parasitic nematodes
Gene
Present in:
N. brasiliensis A. duodenale A. ceylanicum N. americanum S. carpocapsae A. lumbricoides S. ratti S. stercoralis T. canis
npr-19 X        
nape-1       X X 
faah-1         
dagl-2         
magl X X X X X X X X X
abhd-6         
abhd-12         
abhd-5         
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FIG 4 Expression of genes encoding endocannabinoid biosynthetic and degradative enzymes in parasitic nematodes. Nematode expression data
for endocannabinoid biosynthetic enzyme gene nape-1 (A) and degradative enzyme gene faah-1 (B), the monoacylglycerol biosynthetic enzyme
gene dagl-2 (C), and genes for the potential degradative enzymes alpha beta hydrolases (abhd-5 [D] and abhd-12 [E]) and the minor 2-AG
degradative enzyme (abhd-6 [F]) are shown in transcripts per million (TPM). The life stages for S. ratti expression are: free-living female (FLF),
parasitic female (PF), free-living male (FLM), and infective L3 (L). The tissues for expression data for T. canis expression are female gut (1), female
(Continued on next page)
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the supplemental material). On a per-weight basis, adult N. brasiliensis produced the
most 2-AG and DHAG, whereas L4 worms produced OEA. Strikingly, infectious L3
worms produced over 100-fold more AEA than the other life cycle stages or the host
(Fig. 1B). L4 and adult N. brasiliensis worms feed on host tissue and blood; therefore, it
may be possible that some endocannabinoids detected may be host derived. However,
the infectious L3 worms were isolated from culture and concentrations of AEA reached
1,000 pmol per gram of worm, which is 100 to 200 times the level found in upper
intestinal mucosal scrapings (5 to 10 pmol per g of tissue) and 300 to 1,000 times found
in circulation (1 to 3 pmol per ml) (Fig. 1 and reference 16). Thus, the endocannabinoids
measured in L3 worms were likely generated by the parasite. Consistent with the
presence of a functional endocannabinoid system in N. brasiliensis, sequence alignment
of the predicted N. brasiliensis gene encoding NAPE-PLD, the dominant enzyme cata-
lyzing the biosynthesis of fatty acids ethanolamides, including AEA, OEA, and DHEA,
revealed 43% identity and sequence conservation in the functional lactamase domain
(Fig. 5D). To validate that the predicted N. brasiliensis genes encoding endocannabinoid
biosynthetic and degradative enzymes were expressed, we performed quantitative PCR
for predicted nape and faah and the actin gene as a housekeeping gene control (Fig.
5E). nape and faah mRNAs were present in all N. brasiliensis life cycle stages, with the
highest expression in the infectious L3 stage. Overall, these data show for the ﬁrst time
that endocannabinoids are produced by N. brasiliensis and suggest that the endocan-
nabinoid system is also present in parasitic nematodes that infect humans.
DISCUSSION
In this study, we investigated the endocannabinoid signaling system following
infection with N. brasiliensis. While recognized for its critical function in the central and
enteric nervous systems, the endocannabinoid system is also activated by and can
inﬂuence inﬂammatory immune responses (20, 36, 37). For example, 2-AG and AEA are
anti-inﬂammatory, which has provided the basis for the potential therapeutic use of
synthetic cannabinoids, or cannabis, in autoimmune or inﬂammatory diseases (38). Oral
treatment of mice with AEA promoted a tolerogenic immune response and regulatory
macrophages in the intestine that were protective in a nonobese diabetic model (39).
Despite an immune function in the intestine, the functional signiﬁcance of endocan-
nabinoids in intestinal parasite infection has not been examined. Our ﬁnding that
helminth infection triggers signiﬁcant endocannabinoid synthesis that is correlated
with both host health outcomes and parasite fecundity suggests that endocannabi-
noids may be an important player in host-helminth dynamics.
Inhibition of CB1R led to decreased expression of the Th2 cytokine IL-5 in the
intestine and IL-4, IL-5, and IL-10 in the spleen but no difference in the Th1 cytokine
IFN-. This was associated with increased parasite egg and worm burdens, suggesting
that CB1R signaling may be important for the optimal host immune response to keep
helminth burdens in check. Endocannabinoids also signal through CB2R (20); however,
CB2R antagonist treatment did not signiﬁcantly change cytokine responses or helminth
burdens. CB1R and CB2R inhibition was conducted during a short time frame, days 4 to
6 postinfection, and we cannot conﬁrm complete abrogation of CB1R or CB2R signaling
in the intestine with this treatment regime. Future studies with earlier treatment
regimes or CB1R/CB2R-deﬁcient mice may delineate functional differences between
these signaling pathways in helminth infection. Cannabinoid CB1Rs are expressed in
cholecystokinin (CCK)-positive enteroendocrine cells in the duodenum of mice (40) and
ghrelin-expressing cells of the stomach of rats (41), and N. brasiliensis infection in rats
FIG 4 Legend (Continued)
reproductive tract (2), female anterior body (3), male gut (4), male reproductive tract (5), male anterior body (6), and L3 (7). The life stages for N.
americanus expression are adult (A) and infectious L3 (L). The life stages for S. carpocapsae expression are nonactivated infective juveniles (IJs)
(NA IJ), 12-h in vitro activated IJs (VIT 12 h), 9-h in vivo activated IJs (VIV 9h), 12-h in vivo activated IJs (VIV 12h), and 15 h in vivo activated IJs (VIV
15h). The life stages for S. stercoralis expression are nonactivated IJ (NA IJ) and activated IJ (A IJ). The life stages for A. ceylanicum expression are
17 days postinfection (1), 12 days postinfection (2), 5 days postinfection (3), 24-h incubation in hookworm culture media (4), and infective L3 (5).
The life stages for N. brasiliensis expression are adult (1), L4 from mouse lung (2), infectious L3 (3), and eggs (4).
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FIG 5 N. brasiliensis produces endocannabinoids and cannabinoid-like molecules. N. brasiliensis parasites from life
cycle stages were isolated, washed, and assessed for levels of endocannabinoids and endocannabinoid-like
molecules by UPLC/MS/MS. (A) Levels of analytes at various life stages: anandamide (AEA), 2-arachidonoyl-sn-
glycerol (2-AG), oleoylethanolamide (OEA), docosahexaenoylethanolamide (DHEA), and docosahexaenoylglycerol
(DHAG). (B and C) Representative chromatograms of AEA (B) and 2-AG (C). (D) A 68-amino-acid (aa) region of an
alignment of mouse and N. brasiliensis NAPE-PLD (43% shared identity). The alignment region shown is the ﬁrst 68
aa in a 202-aa lactamase (B_2) domain identiﬁed in mouse NAPE-PLD. (E) Quantitative reverse transcription-PCR of
Nippostrongylus life cycle stages for predicted nape and faah.
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is associated with elevations in circulating levels of CCK (4, 42). Thus, it is possible that
helminth infection may induce changes in feeding behavior, as seen in Fig. 2, by a
mechanism that includes endocannabinoid-mediated changes in the production
and/or release of peptides important for feeding behavior, including CCK. We observed
signiﬁcant correlations between endocannabinoid levels, infection-induced weight loss,
and parasite burdens. However, further functional studies are necessary to determine
causal relationships between these multiple parameters and the contribution, if any, of
infection-induced endocannabinoids to feeding behavior.
In addition to host endocannabinoid expression, we show for the ﬁrst time that N.
brasiliensis produces endocannabinoids and that genes encoding endocannabinoid
biosynthetic and degradative enzymes are present in the genomes of multiple parasitic
nematodes, including some of the most common helminth parasites of humans. One
proposed strategy by which parasites modulate host immunity is by releasing mole-
cules that are already native within the host, or at least native-like molecules (43). For
example, A. suum and T. canis have been shown to synthesize morphine or morphine-
like substrates, and morphine is a known immunomodulator (44, 45). It is well recog-
nized that the endocannabinoid system is conserved in a diverse variety of vertebrates,
including pythons (46) and goldﬁsh (47); however, whether it evolved earlier and is
functional in more primitive eukaryotic organisms is less well understood (29). We
observed that N. brasiliensis has predicted genes encoding the NAPE-PLD and FAAH
enzymes that catalyze endocannabinoid synthesis and breakdown. Quantitative PCR
analysis conﬁrmed N. brasiliensis expression of both of these predicted genes. More-
over, mass spectrometry analysis revealed that infectious L3 N. brasiliensis produced
extremely high levels of AEA, reaching 100 to 1,000 times that found in tissue or blood
of mice. A recent study showed that trufﬂes, the fruiting bodies of fungi, produce AEA
potentially as an attractant and feeding stimulant for animals to ensure its dissemina-
tion (48). Given that AEA is anti-inﬂammatory, high-level synthesis at the infectious
stage may also function to dampen the host immune response. It is possible that in
addition to endocannabinoids, N. brasiliensis may produce and release other signaling
molecules endogenous to the host, such as morphine, and that there is overlap in the
biological effects of these molecules on host immunity or behavior. Given the differ-
ence in mass between N. brasiliensis and the host, the endocannabinoids detected in
the infected mice are likely host derived. However, it is possible that N. brasiliensis-
derived endocannabinoids may functionally impact the host at the cellular level. Future
studies are necessary to test these hypotheses.
Inhibition of CB1R signaling signiﬁcantly increased N. brasiliensis egg burden; how-
ever, whether the functional effect was through inﬂuencing the host or alteration of the
endocannabinoid system in N. brasiliensis is unclear. In the host, the increased N.
brasiliensis burdens when CB1R signaling is inhibited could be due to the altered
immune response or to reduced intestinal motility. Indeed, immune cells express both
CB1 and CB2 receptors (49) (i.e., macrophages, dendritic cells, and T cells) and intestinal
epithelial cells express CB1R (14). Whether the CB1R inhibitor-mediated increase in N.
brasiliensis burden was through direct effects on immune cells, effects on the intestinal
epithelial cells, or a combination of such effects is unclear and would require further
studies. In addition to regulating immune responses, the endocannabinoid system
throughout the gastrointestinal tract plays a variety of physiological roles, including the
control of motility, immune function, mucosal barrier function, and feeding behavior
(50–52). Although outside the scope of the present study, future studies should include
an evaluation of the impact that endocannabinoid-induced changes in intestinal
motility have on egg burden. Furthermore, it is possible that endocannabinoid metab-
olism and/or release may be secondarily affected by perturbations in physiological
responses governed by endocannabinoids themselves. It is also possible that CB1R
inhibition could directly affect N. brasiliensis. Although the N. brasiliensis genome does
not have canonical cannabinoid receptor genes, genes encoding endocannabinoid
degradative enzymes are present in the N. brasiliensis genome, suggesting that N.
brasiliensis may also respond to the endocannabinoids it produces through an as-yet-
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unidentiﬁed receptor. Consistent with this, C. elegans produces and responds to
cannabinoids through NPR-19 (31–33). Inhibiting CB1R signaling was ultimately bene-
ﬁcial to N. brasiliensis, leading to improved parasite fertility. Why N. brasiliensis would
produce endocannabinoids that adversely affect its fertility is unclear at present. Our
data, however, support a functional impact of the host and parasite endocannabinoid
system and suggest that further studies delineating the beneﬁcial or detrimental
function of endocannabinoids in the host versus the helminth are warranted. For
example, the timing of cannabinoid receptor signaling inhibition may be critical. In our
studies, we inhibited CB1R signaling after adult parasite establishment in the intestine;
however, N. brasiliensis produces the most AEA during the initial infection, possibly as
an anti-inﬂammatory mechanism to downregulate the host immune response. N.
brasiliensis-derived AEA may also prevent excessive host inﬂammation that could lead
to host mortality, which would be an equally adverse outcome for the helminth.
Notwithstanding this, our discovery of parasite-derived endocannabinoids implicates
the endocannabinoid system as a primitive pathway that contributes to host-pathogen
interaction and suggests that investigation of the existence of the endocannabinoid
system in other pathogens is warranted.
The complexity of host-helminth interaction and the numerous factors that inﬂu-
ence the health outcomes for the parasite and the host are increasingly recognized. In
addition to an optimized Th2 response for parasite expulsion, parasitic helminths
trigger a multitude of nonimmune pathways that affect physiological processes, such
as feeding and metabolism, but can also inﬂuence the immune response (53–55). Our
ﬁndings suggest that the endocannabinoid system is a previously unrecognized con-
tributor to this dynamic process and may therefore have a signiﬁcant impact on the
host’s health outcome beyond parasite expulsion.
MATERIALS AND METHODS
Parasite. The Nippostrongylus brasiliensis life cycle was maintained in Sprague-Dawley rats, as
previously described (56, 57). Hatched infectious L3 larvae were recovered from 1- to 2-week-old fecal
egg cultures by a Baermann apparatus. L4 larvae were recovered from lung tissue of day 2 infected rats
by manual picking from coarsely minced lung tissue in media after 2 h of incubation at 37°C. Adult N.
brasiliensis parasites were recovered from day 6 to 8 N. brasiliensis infected rats by dissection and slitting
of the whole small intestine, followed by 2 h of incubation in warm PBS and manual picking of the worms
from the intestinal tissue or supernatant. Eggs in the feces of infected mice and rats were counted using
a McMaster counting chamber. For endocannabinoid quantiﬁcation, parasites were washed three times
in excess PBS, counted, and weighed.
Mice and tissue recovery. C57BL/6 mice were purchased from the Jackson Laboratory or bred
in-house. All mice in the experiment were age-matched (6- to 8-week-old) males and females housed in
a speciﬁc-pathogen-free facility. Mice were anesthetized with isoﬂurane and injected subcutaneously
with 500 N. brasiliensis L3 larvae. Behavior was assessed using single-housing units (TSE Systems,
Chesterﬁeld, MO). Mice were placed into units 3 days prior to recording for acclimation, and daily feeding
was monitored using Phenomaster software (TSE Systems). Where indicated, mice were treated intra-
peritoneally with a vehicle control (7.5% DMSO, 7.5% Tween 80, and 85% saline), CB1R antagonist
AM6545 (10 mg/kg of body weight), or CB2R antagonist AM630 (10 mg/kg). Blood recovery was done by
cardiac puncture into tubes containing 7.2 mg of EDTA. Following excision of the small intestine, mucosa
was stripped and recovered for endocannabinoid quantiﬁcation. One-centimeter jejunal tissues were
weighed and homogenized in 0.5 ml of PBS with Mini-Beadbeater-96 (BioSpec Products) at 4°C, and
supernatants were collected after centrifugation (4,000	 g for 15 min at 4°C) for cytokine quantiﬁcation.
All protocols for animal use and euthanasia were approved by the University of California, Riverside
Institutional Animal Care and Use Committee (https://or.ucr.edu/ori/committees/iacuc.aspx; protocols
A-20150028E and A-20170036) and were in accordance with the National Institutes of Health guidelines.
Animal studies are in accordance with the provisions established by the Animal Welfare Act and the
Public Health Service Policy on Humane Care and Use of Laboratory Animals (71).
Lipid extraction and FAE and MAG analysis. Lipid extraction and analysis were performed as
previously described (16, 36). Brieﬂy, frozen tissue or worms (2,000 L3 worms/sample, 400 L4 worms/
sample, and 100 adults/sample) were homogenized in 1.0 ml of methanol solution containing the
internal standards [2H5]2-AG, [2H4]AEA, and [2H4]OEA (Cayman Chemical, Ann Arbor, MI). Lipids were
extracted with chloroform (2 ml) and washed with water (1 ml). Lipids were similarly extracted from
plasma samples, with the exception of a 0.9% saline wash replacing water (0.1 ml of plasma at the
expense of saline). Organic phases were collected and separated by open-bed silica gel column
chromatography as previously described (15). Eluate was gently dried under N2 stream (99.998% pure)
and resuspended in 0.1 ml of methanol-chloroform (9:1), with 1-l injection for ultraperformance liquid
chromatography-tandem mass spectrometry (UPLC/MS/MS) analysis.
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Data were acquired using an Acquity I class UPLC with in-line connection to a Xevo TQ-S micro-
triple-quadrupole mass spectrometer (Waters Corporation, Milford, MA) with electrospray ionization (ESI)
sample delivery. Lipids were quantiﬁed using a stable isotope dilution method detecting proton or
sodium adducts of the molecular ions [M 
 H/Na]
 in multiple-reaction monitoring (MRM) mode.
Extracted ion chromatograms for MRM transitions were used to quantify analytes 2-AG (m/z  379.3 
287.3), 2-docosahexaenoyl glycerol (2-DG) (m/z  403.3  311.2), AEA (m/z  348.3  62.0), OEA (m/z 
326.4 62.1), DHEA, (m/z 372.3 62.0), 19:2 MAG (m/z 386.4 277.2), with [2H5]2-AG (m/z 384.3
93.4), [2H4]AEA (m/z  352.4  66.1), and [2H4]OEA (m/z  330.4  66.0) as internal standards. Controls
included one “blank” sample that was processed and analyzed in the samemanner as all samples, except that
no tissue was included. This control revealed no detectable endocannabinoids and related lipids included in
our analysis.
Functional enzyme assays of DGL and MGL activities. Data for free fatty acids (FFA) (19:2 FFA,
product of the MGL assay) were measured using the UPLC/MS/MS instrument as described above.
Mobile-phase compositions for 19:2 FFA were the same as described above, but the ﬂow gradient began
at a ﬂow rate of 0.4 ml/min: 90% methanol for 0.1 min, 90% to 100% methanol for 0.1 to 2.0 min, 100%
methanol for 2.0 to 2.1 min, 100% to 90% methanol for 2.1 to 2.2 min, and 90% methanol for 2.2 to 2.5
min. The product of DGL assay, 19:2 MAG, was analyzed exactly as described above for other MAGs. MS
detection of fatty acids was in negative-ion mode with capillary voltage maintained at 1.10 kV. Cone
voltages for respective analytes were as follows: 19:2 FFA, 48 V, and 17:1 FFA, 64 V. Lipids were quantiﬁed
using a dilution series detecting deprotonated molecular ions in selected ion recording (SIR) mode.
Extracted ion chromatograms for SIR masses were used to quantify the analyte 19:2 FFA (m/z  293.3)
and the internal standard 17:1 FFA (m/z  267.2).
Tissue preparation. Intestinal epithelium was collected as described above, and approximately 100
mg of frozen tissue was homogenized in 2 ml of ice-cold 50 mM Tris-HCl–320 mM sucrose (pH 7.5) buffer.
Homogenates were centrifuged at 800 	 g for 10 min while kept at 4°C, and supernatant was collected.
Protein supernatants were sonicated twice for 10 s and then freeze-thawed in liquid nitrogen twice.
Samples were spun again, as described above, and supernatant was quantiﬁed with the bicinchoninic
acid (BCA) assay and diluted with Tris-HCl–sucrose buffer.
DGL activity assay. Twenty-ﬁve-microgram tissue homogenates, in 0.1 ml of Tris-HCl–sucrose (pH
7.5), were incubated with 0.3 M JZL184 (MGL inhibitor; Cayman Chemical, Ann Arbor, MI [58]) for 10 min
at room temperature. Homogenates were incubated with 0.1 ml of solution of Tris-HCl with 0.2% Triton
X-100 (pH 7.0) containing 20 nmol of dinonadecadienoin (Nu-Chek Prep, Waterville, MN; ﬁnal volume, 0.2
ml/reaction) at 37°C for 30 min. The reaction was stopped by adding 1 ml of MeOH containing 25 pmol
of [2H5]2-AG. Lipids were extracted as described above and analyzed via UPLC/MS/MS.
MGL activity assay. Ten-microgram tissue homogenates, in 0.1 ml of Tris-HCl–sucrose (pH 7.5), were
incubated with 0.4 ml of solution of Tris-HCl with 0.1% bovine serum albumin (BSA; pH 8.0) containing
50 nmol of nonadecadienoin (Nu-Chek Prep; ﬁnal volume, 0.5 ml/reaction) at 37°C for 10 min. The
reaction was stopped by adding 1 ml of MeOH containing 10 nmol of heptadecanoic acid (Nu-Chek
Prep). Lipids were extracted as described above and analyzed via UPLC/MS/MS.
Cytokine quantiﬁcation. (i) ELISA. IL-5 quantiﬁcation of intestinal homogenate and spleen super-
natants was performed by standard sandwich enzyme-linked immunosorbent assay (ELISA) according to
previously described protocols (56).
(ii) Cytokine bead array. IL-4, IFN-, and IL-10 quantiﬁcation was performed on intestinal homog-
enate and supernatants from 72-h-stimulated splenocytes (5 	 106/well; 0.5 g/ml of anti-CD3 and
anti-CD28) using the Th1/Th2 CBA assay (BD Biosciences) according to the manufacturer’s instructions.
RNA quantiﬁcation. Mouse tissue recovered for RNA extraction was ﬁrst incubated overnight in
RNAlater (Qiagen) at 4°C and then extracted by TRIzol (Life Technologies). iScript reverse transcriptase
(Bio-Rad) was used for cDNA synthesis. Real-time PCR was performed using iTaq Universal SYBR green
Supermix (Bio-Rad) and the Bio-Rad CFX Connect. 18S primers were purchased from Qiagen, and Cnr1
and Cnr2 primers were purchased from Bio-Rad.
L3 infective juveniles (3 replicates of 500 to 1,000) were collected from cultured rat fecal plates. L4
worms (3 replicates of 100 to 500) were collected from dissected lungs of infected rats 2 days
postinfection. Adult worms (3 replicates of 100 to 200) were collected from dissected intestines of
infected rats. Worms were washed in double-distilled water (ddH2O), ﬂash-frozen, and then homoge-
nized in RiboZol (VWR) using pellet pestles and a pestle motor (Fisher Scientiﬁc and VWR). RNA was
extracted according to RiboZol manufacturer instructions. Reverse transcription was done using Proto-
Script II reverse transcriptase (New England BioLabs [NEB]), followed by real-time PCR as described above.
Primer sequences were as follows: N. brasiliensis actin gene, ACGACGTGGCAGCTCTCGTTGTGG (forward)
and GGTGCTTCGGTCAGCAGCACGGGA (reverse); N. brasiliensis faah gene, TCGGAGCAGGTGTTGTGAAGA
(forward) and AGCCGGTACCACGGATCTGA (reverse); and N. brasiliensis nape gene, GGCGTACAGTCCAC
GATGGTT (forward) and GGTGCTTCGGCTCGAGGTAG (reverse).
Gene orthology analysis and protein alignment. To identify enzymes and regulatory proteins
involved in lipolysis and endocannabinoid signaling, we leveraged previously identiﬁed orthologs in C.
elegans (31, 59). WormBase ParaSite (version WBPS9) was consulted to identify putative orthologs of
these genes in several parasitic nematodes. To validate the putative parasitic nematode orthologs, we
performed an orthology analysis using available predicted protein data sets from WormBase release
WSPS: Ancylostoma ceylanicum, Ancylostoma duodenale, Ascaris lumbricoides, Ascaris suum, C. elegans,
Necator americanus, N. brasiliensis, Steinernema carpocapsae, Strongyloides ratti, Strongyloides stercoralis,
and Toxocara canis. Version 1.4 of the OrthoMCL pipeline was used to cluster proteins into families of
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orthologous genes, with default settings and the BLAST parameters recommended in the OrthoMCL
documentation (59).
The NAPE-PLD gene was further explored by aligning the sequences of mouse NAPE-PLD and the
putative homolog from N. brasiliensis. Protein sequences were aligned using MUSCLE (60) and visualized
using Mesquite (version 3.2). The accession numbers of the proteins used are NP_848843 for the mouse
NAPE-PLD from GenBank and NBR_0001270801-mRNA-1 for the N. brasiliensis NAPE-PLD from WormBase
ParaSite. The -lactamase domain in the alignment was identiﬁed using the Smart protein database (61).
Gene expression analysis. To determine if genes for the endocannabinoid system are expressed in
other parasitic nematodes, we downloaded the RNA-seq data for T. canis (62) (SRR1707010 and
SRR1707031-6), S. ratti (63) (ERR299168-79 and ERR225783-4), S. stercoralis (64) (ERR146945-6 and
ERR146948-9), A. suum (65) (SRR851186-95), N. americanus (66) (SRR609895 and SRR609951), N. brasil-
iensis (67) (PRJEB16076), and A. ceylanicum (68) (SRR1124912-4 and SRR1124985-6) from the NCBI
database. The published RNA-seq data for N. brasiliensis were downloaded from the European Nucleotide
Archive (http://www.ebi.ac.uk/). The reads were mapped to each species’ indexed transcriptome (down-
loaded from WormBase ParaSite, WSPS9) with bowtie 1.0.0 in paired-end mode with the following
settings: bowtie –X 800 -m 200 -S –seedlen 25 –trim3 [50 or 100] -n 2 –offrate 1 (69). Gene expression
was quantiﬁed with RSEM version 1.2.31 (70).
Statistical analysis. GraphPad Prism software was used for statistical analyses. Where appropriate,
Student’s t test (for normal distribution data), one-way analysis of variance (ANOVA) (for analysis of more
than two groups), two-way ANOVA (for analysis of more than one experiment), linear regression, and
nonparametric Spearman correlation (for correlation analysis) were performed. Statistical signiﬁcance is
indicated in Table 1 and in ﬁgures as follows: *, P  0.05; **, P  0.01; and ***, P  0.0001. To evaluate
CB1R inhibitor effect on N. brasiliensis burdens across experimental repeats, we employed linear mixed
models. The inhibitor was tested as the main effect, which was adjusted by baseline weight and the
weight on day 3; the experimental cooperation was the random effect. On the basis of the distribution
types for egg and worm, the corresponding distribution families were Gamma and Poisson, respectively.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/IAI
.00441-18.
SUPPLEMENTAL FILE 1, PDF ﬁle, 2.0 MB.
ACKNOWLEDGMENTS
These studies were supported by the NIH (grants 1R01AI091759-01A1 and
R21AI137830 to M.G.N., R00DA034009 to N.V.D., K22AI119155 to A.R.D., and
R21AI135500 to M.G.N., N.V.D., and A.R.D.) and initial complement from the UCR School
of Medicine (to M.G.N. and N.V.D.).
We thank Spencer Wang, Sarah Bobardt, and Mark Barnes for assistance with the
Nippostrongylus brasiliensis life cycle and assays.
M.G.N. and N.V.D. conceived and designed the experiments. H.M.B., J.C.J., D.A., D.L.,
J.K., and M.G.N. performed the experiments. J.C.J., D.A., H.M.B., N.V.D., D.L., S.G., and
M.G.N. analyzed the data. M.M. and A.R.D. contributed bioinformatics analysis. M.G.N.,
N.V.D., and A.R.D. wrote the paper.
REFERENCES
1. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. 2008.
Helminth infections: the great neglected tropical diseases. J Clin Invest
118:1311–1321. https://doi.org/10.1172/JCI34261.
2. Stephensen CB. 1999. Burden of infection on growth failure. J Nutr
129:534S–538S. https://doi.org/10.1093/jn/129.2.534S.
3. Shea-Donohue T, Qin B, Smith A. 2017. Parasites, nutrition, immune
responses and biology of metabolic tissues. Parasite Immunol 39:
e12422. https://doi.org/10.1111/pim.12422.
4. Ovington KS. 1986. Physiological responses of rats to primary infection
with Nippostrongylus brasiliensis. J Helminthol 60:307–312. https://doi
.org/10.1017/S0022149X00008543.
5. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando
JK, Chawla A, Locksley RM. 2011. Eosinophils sustain adipose alterna-
tively activated macrophages associated with glucose homeostasis. Sci-
ence 332:243–247. https://doi.org/10.1126/science.1201475.
6. Yang Z, Grinchuk V, Smith A, Qin B, Bohl JA, Sun R, Notari L, Zhang Z,
Sesaki H, Urban JF, Shea-Donohue T, Zhao A. 2013. Parasitic nematode-
induced modulation of body weight and associated metabolic dysfunc-
tion in mouse models of obesity. Infect Immun 81:1905–1914. https://
doi.org/10.1128/IAI.00053-13.
7. Barnes MA, Carson MJ, Nair MG. 2015. Non-traditional cytokines: how
catecholamines and adipokines inﬂuence macrophages in immunity,
metabolism and the central nervous system. Cytokine 72:210–219.
https://doi.org/10.1016/j.cyto.2015.01.008.
8. Howitt MR, Lavoie S, Michaud M, Blum AM, Tran SV, Weinstock JV, Gallini
CA, Redding K, Margolskee RF, Osborne LC, Artis D, Garrett WS. 2016.
Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immu-
nity in the gut. Science 351:1329–1333. https://doi.org/10.1126/science
.aaf1648.
9. DiPatrizio NV, Piomelli D. 2012. The thrifty lipids: endocannabinoids and
the neural control of energy conservation. Trends Neurosci 35:403–411.
https://doi.org/10.1016/j.tins.2012.04.006.
10. Simon V, Cota D. 2017. Mechanisms in endocrinology: endocannabi-
noids and metabolism: past, present and future. Eur J Endocrinol 176:
R309–R324. https://doi.org/10.1530/EJE-16-1044.
11. Di Marzo V, Melck D, Bisogno T, De Petrocellis L. 1998. Endocannabinoids:
endogenous cannabinoid receptor ligands with neuromodulatory ac-
tion. Trends Neurosci 21:521–528. https://doi.org/10.1016/S0166-2236
(98)01283-1.
12. Munro S, Thomas KL, Abu-Shaar M. 1993. Molecular characterization of
Batugedara et al. Infection and Immunity
November 2018 Volume 86 Issue 11 e00441-18 iai.asm.org 14
a peripheral receptor for cannabinoids. Nature 365:61–65. https://doi
.org/10.1038/365061a0.
13. Galiègue S, Mary S, Marchand J, Dussossoy D, Carrière D, Carayon P,
Bouaboula M, Shire D, Le Fur G, Casellas P. 1995. Expression of central
and peripheral cannabinoid receptors in human immune tissues and
leukocyte subpopulations. Eur J Biochem 232:54–61. https://doi.org/10
.1111/j.1432-1033.1995.tb20780.x.
14. DiPatrizio NV, Igarashi M, Narayanaswami V, Murray C, Gancayco J,
Russell A, Jung KM, Piomelli D. 2015. Fasting stimulates 2-AG biosyn-
thesis in the small intestine: role of cholinergic pathways. Am J
Physiol Regul Integr Comp Physiol 309:R805–R813. https://doi.org/10
.1152/ajpregu.00239.2015.
15. DiPatrizio NV, Astarita G, Schwartz G, Li X, Piomelli D. 2011. Endocan-
nabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci
U S A 108:12904–12908. https://doi.org/10.1073/pnas.1104675108.
16. Argueta DA, DiPatrizio NV. 2017. Peripheral endocannabinoid signaling
controls hyperphagia in western diet-induced obesity. Physiol Behav
171:32–39. https://doi.org/10.1016/j.physbeh.2016.12.044.
17. Correa F, Hernangómez M, Mestre L, Loría F, Spagnolo A, Docagne F, Di
Marzo V, Guaza C. 2010. Anandamide enhances IL-10 production in
activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK,
and NF-kappaB. Glia 58:135–147. https://doi.org/10.1002/glia.20907.
18. Nair MG, Herbert DR. 2016. Immune polarization by hookworms: taking
cues from T helper type 2, type 2 innate lymphoid cells and alternatively
activated macrophages. Immunology 148:115–124. https://doi.org/10
.1111/imm.12601.
19. Storr MA, Keenan CM, Zhang H, Patel KD, Makriyannis A, Sharkey KA.
2009. Activation of the cannabinoid 2 receptor (CB2) protects against
experimental colitis. Inﬂamm Bowel Dis 15:1678–1685. https://doi.org/
10.1002/ibd.20960.
20. Turcotte C, Blanchet MR, Laviolette M, Flamand N. 2016. The CB2 recep-
tor and its role as a regulator of inﬂammation. Cell Mol Life Sci 73:
4449–4470. https://doi.org/10.1007/s00018-016-2300-4.
21. Bouchery T, Filbey K, Shepherd A, Chandler J, Patel D, Schmidt A, Camberis
M, Peignier A, Smith AAT, Johnston K, Painter G, Pearson M, Giacomin P,
Loukas A, Bottazzi ME, Hotez P, LeGros G. 2018. A novel blood-feeding
detoxiﬁcation pathway in Nippostrongylus brasiliensis L3 reveals a potential
checkpoint for arresting hookworm development. PLoS Pathog 14:
e1006931. https://doi.org/10.1371/journal.ppat.1006931.
22. Klein TW. 2005. Cannabinoid-based drugs as anti-inﬂammatory thera-
peutics. Nat Rev Immunol 5:400–411. https://doi.org/10.1038/nri1602.
23. Rodríguez de Fonseca F, Navarro M, Gómez R, Escuredo L, Nava F, Fu J,
Murillo-Rodríguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C,
Piomelli D. 2001. An anorexic lipid mediator regulated by feeding.
Nature 414:209–212. https://doi.org/10.1038/35102582.
24. Randall PA, Vemuri VK, Segovia KN, Torres EF, Hosmer S, Nunes EJ,
Santerre JL, Makriyannis A, Salamone JD. 2010. The novel cannabinoid
CB1 antagonist AM6545 suppresses food intake and food-reinforced
behavior. Pharmacol Biochem Behav 97:179–184. https://doi.org/10
.1016/j.pbb.2010.07.021.
25. Tam J, Vemuri VK, Liu J, Bátkai S, Mukhopadhyay B, Godlewski G,
Osei-Hyiaman D, Ohnuma S, Ambudkar SV, Pickel J, Makriyannis A,
Kunos G. 2010. Peripheral CB1 cannabinoid receptor blockade improves
cardiometabolic risk in mouse models of obesity. J Clin Invest 120:
2953–2966. https://doi.org/10.1172/JCI42551.
26. Elphick MR. 2012. The evolution and comparative neurobiology of en-
docannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 367:
3201–3215. https://doi.org/10.1098/rstb.2011.0394.
27. Galles C, Prez GM, Penkov S, Boland S, Porta EOJ, Altabe SG, Labadie GR,
Schmidt U, Knölker HJ, Kurzchalia TV, de Mendoza D. 2018. Endocan-
nabinoids in Caenorhabditis elegans are essential for the mobilization of
cholesterol from internal reserves. Sci Rep 8:6398. https://doi.org/10
.1038/s41598-018-24925-8.
28. Savinainen JR, Saario SM, Laitinen JT. 2012. The serine hydrolases MAGL,
ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling
through cannabinoid receptors. Acta Physiol (Oxf) 204:267–276. https://
doi.org/10.1111/j.1748-1716.2011.02280.x.
29. Lehtonen M, Reisner K, Auriola S, Wong G, Callaway JC. 2008. Mass-
spectrometric identiﬁcation of anandamide and 2-arachidonoylglycerol
in nematodes. Chem Biodivers 5:2431–2441. https://doi.org/10.1002/
cbdv.200890208.
30. McPartland JM, Matias I, Di Marzo V, Glass M. 2006. Evolutionary origins
of the endocannabinoid system. Gene 370:64–74. https://doi.org/10
.1016/j.gene.2005.11.004.
31. Lucanic M, Held JM, Vantipalli MC, Klang IM, Graham JB, Gibson BW,
Lithgow GJ, Gill MS. 2011. N-acylethanolamine signalling mediates the
effect of diet on lifespan in Caenorhabditis elegans. Nature 473:226–229.
https://doi.org/10.1038/nature10007.
32. Oakes MD, Law WJ, Clark T, Bamber BA, Komuniecki R. 2017. Cannabi-
noids activate monoaminergic signaling to modulate key C. elegans
behaviors. J Neurosci 37:2859–2869. https://doi.org/10.1523/JNEUROSCI
.3151-16.2017.
33. Reis Rodrigues P, Kaul TK, Ho JH, Lucanic M, Burkewitz K, Mair WB, Held
JM, Bohn LM, Gill MS. 2016. Synthetic ligands of cannabinoid receptors
affect Dauer formation in the nematode Caenorhabditis elegans. G3
(Bethesda) 6:1695–1705. https://doi.org/10.1534/g3.116.026997.
34. Howe KL, Bolt BJ, Shaﬁe M, Kersey P, Berriman M. 2017. WormBase
ParaSite—a comprehensive resource for helminth genomics. Mol
Biochem Parasitol 215:2–10. https://doi.org/10.1016/j.molbiopara.2016
.11.005.
35. Holroyd N, Sanchez-Flores A. 2012. Producing parasitic helminth refer-
ence and draft genomes at the Wellcome Trust Sanger Institute. Parasite
Immunol 34:100–107. https://doi.org/10.1111/j.1365-3024.2011.01311.x.
36. Dotsey E, Ushach I, Pone E, Nakajima R, Jasinskas A, Argueta DA,
Dillon A, DiPatrizio N, Davies H, Zlotnik A, Crompton PD, Felgner PL.
2017. Transient cannabinoid receptor 2 blockade during immuniza-
tion heightens intensity and breadth of antigen-speciﬁc antibody
responses in young and aged mice. Sci Rep 7:42584. https://doi.org/
10.1038/srep42584.
37. Di Marzo V, Izzo AA. 2006. Endocannabinoid overactivity and intes-
tinal inﬂammation. Gut 55:1373–1376. https://doi.org/10.1136/gut
.2005.090472.
38. Katz D, Katz I, Porat-Katz BS, Shoenfeld Y. 2017. Medical cannabis:
another piece in the mosaic of autoimmunity? Clin Pharmacol Ther
101:230–238. https://doi.org/10.1002/cpt.568.
39. Acharya N, Penukonda S, Shcheglova T, Hagymasi AT, Basu S, Srivastava
PK. 2017. Endocannabinoid system acts as a regulator of immune ho-
meostasis in the gut. Proc Natl Acad Sci U S A 114:5005–5010. https://
doi.org/10.1073/pnas.1612177114.
40. Sykaras AG, Demenis C, Case RM, McLaughlin JT, Smith CP. 2012. Duo-
denal enteroendocrine I-cells contain mRNA transcripts encoding key
endocannabinoid and fatty acid receptors. PLoS One 7:e42373. https://
doi.org/10.1371/journal.pone.0042373.
41. Senin LL, Al-Massadi O, Folgueira C, Castelao C, Pardo M, Barja-
Fernandez S, Roca-Rivada A, Amil M, Crujeiras AB, Garcia-Caballero T,
Gabellieri E, Leis R, Dieguez C, Pagotto U, Casanueva FF, Seoane LM.
2013. The gastric CB1 receptor modulates ghrelin production through
the mTOR pathway to regulate food intake. PLoS One 8:e80339. https://
doi.org/10.1371/journal.pone.0080339.
42. Gay J, Ressayre L, Garcia-Villar R, Bueno L, Fioramonti J. 2003. Alteration of
CCK-induced satiety in post-Nippostrongylus brasiliensis-infected rats. Brain
Behav Immun 17:35–42. https://doi.org/10.1016/S0889-1591(02)00034-X.
43. Else KJ. 2005. Have gastrointestinal nematodes outwitted the immune
system? Parasite Immunol 27:407–415. https://doi.org/10.1111/j.1365
-3024.2005.00788.x.
44. Goumon Y, Casares F, Pryor S, Ferguson L, Brownawell B, Cadet P, Rialas
CM, Welters ID, Sonetti D, Stefano GB. 2000. Ascaris suum, an intestinal
parasite, produces morphine. J Immunol 165:339–343. https://doi.org/
10.4049/jimmunol.165.1.339.
45. Golabi M, Naem S, Imani M, Dalirezh N. 2016. Evidence of morphine like
substance and mu-opioid receptor expression in Toxacara canis
(Nematoda: Ascaridae). Veterinary Research Forum 7:335–339.
46. Astarita G, Rourke BC, Andersen JB, Fu J, Kim JH, Bennett AF, Hicks JW,
Piomelli D. 2006. Postprandial increase of oleoylethanolamide mobiliza-
tion in small intestine of the Burmese python (Python molurus). Am J
Physiol Regul Integr Comp Physiol 290:R1407–R1412. https://doi.org/10
.1152/ajpregu.00664.2005.
47. Cottone E, Pomatto V, Cerri F, Campantico E, Mackie K, Delpero M,
Guastalla A, Dati C, Bovolin P, Franzoni MF. 2013. Cannabinoid receptors
are widely expressed in goldﬁsh: molecular cloning of a CB2-like recep-
tor and evaluation of CB1 and CB2 mRNA expression proﬁles in different
organs. Fish Physiol Biochem 39:1287–1296. https://doi.org/10.1007/
s10695-013-9783-9.
48. Pacioni G, Rapino C, Zarivi O, Falconi A, Leonardi M, Battista N, Colafarina
S, Sergi M, Bonﬁgli A, Miranda M, Barsacchi D, Maccarrone M. 2015.
Trufﬂes contain endocannabinoid metabolic enzymes and anandamide.
Phytochemistry 110:104–110. https://doi.org/10.1016/j.phytochem.2014
.11.012.
Endocannabinoids in Helminth Infection Infection and Immunity
November 2018 Volume 86 Issue 11 e00441-18 iai.asm.org 15
49. Heng TS, Painter MW, Immunological Genome Project Consortium. 2008.
The Immunological Genome Project: networks of gene expression in im-
mune cells. Nat Immunol 9:1091–1094. https://doi.org/10.1038/ni1008
-1091.
50. DiPatrizio NV. 2016. Endocannabinoids in the gut. Cannabis Cannabinoid
Res 1:67–77. https://doi.org/10.1089/can.2016.0001.
51. Izzo AA, Sharkey KA. 2010. Cannabinoids and the gut: new develop-
ments and emerging concepts. Pharmacol Ther 126:21–38. https://doi
.org/10.1016/j.pharmthera.2009.12.005.
52. Cani PD, Plovier H, Van Hul M, Geurts L, Delzenne NM, Druart C, Everard
A. 2016. Endocannabinoids—at the crossroads between the gut micro-
biota and host metabolism. Nat Rev Endocrinol 12:133–143. https://doi
.org/10.1038/nrendo.2015.211.
53. Goodridge HS, Marshall FA, Else KJ, Houston KM, Egan C, Al-Riyami L,
Liew FY, Harnett W, Harnett MM. 2005. Immunomodulation via novel
use of TLR4 by the ﬁlarial nematode phosphorylcholine-containing
secreted product, ES-62. J Immunol 174:284–293. https://doi.org/10
.4049/jimmunol.174.1.284.
54. Winter AD, Gillan V, Maitland K, Emes RD, Roberts B, McCormack G, Weir
W, Protasio AV, Holroyd N, Berriman M, Britton C, Devaney E. 2015. A
novel member of the let-7 microRNA family is associated with develop-
mental transitions in ﬁlarial nematode parasites. BMC Genomics 16:331.
https://doi.org/10.1186/s12864-015-1536-y.
55. Riner DK, Ferragine CE, Maynard SK, Davies SJ. 2013. Regulation of
innate responses during pre-patent schistosome infection provides an
immune environment permissive for parasite development. PLoS Pat-
hog 9:e1003708. https://doi.org/10.1371/journal.ppat.1003708.
56. Chen G, Wang SH, Jang JC, Odegaard JI, Nair MG. 2016. Comparison of
RELMalpha and RELMbeta single- and double-gene-deﬁcient mice re-
veals that RELMalpha expression dictates inﬂammation and worm ex-
pulsion in hookworm infection. Infect Immun 84:1100–1111. https://doi
.org/10.1128/IAI.01479-15.
57. Jang JC, Chen G, Wang SH, Barnes MA, Chung JI, Camberis M, Le Gros G,
Cooper PJ, Steel C, Nutman TB, Lazar MA, Nair MG. 2015. Macrophage-
derived human resistin is induced in multiple helminth infections and
promotes inﬂammatory monocytes and increased parasite burden. PLoS
Pathog 11:e1004579. https://doi.org/10.1371/journal.ppat.1004579.
58. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG,
Nguyen PT, Ramesh D, Booker L, Burston JJ, Thomas EA, Selley DE,
Sim-Selley LJ, Liu QS, Lichtman AH, Cravatt BF. 2010. Chronic monoacyl-
glycerol lipase blockade causes functional antagonism of the endocan-
nabinoid system. Nat Neurosci 13:1113–1119. https://doi.org/10.1038/
nn.2616.
59. Li L, Stoeckert CJ, Roos DS. 2003. OrthoMCL: identiﬁcation of ortholog
groups for eukaryotic genomes. Genome Res 13:2178–2189. https://doi
.org/10.1101/gr.1224503.
60. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accu-
racy and high throughput. Nucleic Acids Res 32:1792–1797. https://doi
.org/10.1093/nar/gkh340.
61. Letunic I, Doerks T, Bork P. 2015. SMART: recent updates, new develop-
ments and status in 2015. Nucleic Acids Res 43:D257–D260. https://doi
.org/10.1093/nar/gku949.
62. Zhu XQ, Korhonen PK, Cai H, Young ND, Nejsum P, von Samson-
Himmelstjerna G, Boag PR, Tan P, Li Q, Min J, Yang Y, Wang X, Fang X,
Hall RS, Hofmann A, Sternberg PW, Jex AR, Gasser RB. 2015. Genetic
blueprint of the zoonotic pathogen Toxocara canis. Nat Commun
6:6145. https://doi.org/10.1038/ncomms7145.
63. Hunt VL, Tsai IJ, Coghlan A, Reid AJ, Holroyd N, Foth BJ, Tracey A, Cotton
JA, Stanley EJ, Beasley H, Bennett HM, Brooks K, Harsha B, Kajitani R,
Kulkarni A, Harbecke D, Nagayasu E, Nichol S, Ogura Y, Quail MA, Randle
N, Xia D, Brattig NW, Soblik H, Ribeiro DM, Sanchez-Flores A, Hayashi T,
Itoh T, Denver DR, Grant W, Stoltzfus JD, Lok JB, Murayama H, Wastling
J, Streit A, Kikuchi T, Viney M, Berriman M. 2016. The genomic basis of
parasitism in the Strongyloides clade of nematodes. Nat Genet 48:
299–307. https://doi.org/10.1038/ng.3495.
64. Stoltzfus JD, Minot S, Berriman M, Nolan TJ, Lok JB. 2012. RNAseq
analysis of the parasitic nematode Strongyloides stercoralis reveals di-
vergent regulation of canonical dauer pathways. PLoS Negl Trop Dis
6:e1854. https://doi.org/10.1371/journal.pntd.0001854.
65. Rosa BA, Jasmer DP, Mitreva M. 2014. Genome-wide tissue-speciﬁc gene
expression, co-expression and regulation of co-expressed genes in adult
nematode Ascaris suum. PLoS Negl Trop Dis 8:e2678. https://doi.org/10
.1371/journal.pntd.0002678.
66. Tang YT, Gao X, Rosa BA, Abubucker S, Hallsworth-Pepin K, Martin J,
Tyagi R, Heizer E, Zhang X, Bhonagiri-Palsikar V, Minx P, Warren WC,
Wang Q, Zhan B, Hotez PJ, Sternberg PW, Dougall A, Gaze ST, Mulvenna
J, Sotillo J, Ranganathan S, Rabelo EM, Wilson RW, Felgner PL, Bethony
J, Hawdon JM, Gasser RB, Loukas A, Mitreva M. 2014. Genome of the
human hookworm Necator americanus. Nat Genet 46:261–269. https://
doi.org/10.1038/ng.2875.
67. Sotillo J, Sanchez-Flores A, Cantacessi C, Harcus Y, Pickering D, Bouchery
T, Camberis M, Tang SC, Giacomin P, Mulvenna J, Mitreva M, Berriman M,
LeGros G, Maizels RM, Loukas A. 2014. Secreted proteomes of different
developmental stages of the gastrointestinal nematode Nippostrongy-
lus brasiliensis. Mol Cell Proteomics 13:2736–2751. https://doi.org/10
.1074/mcp.M114.038950.
68. Schwarz EM, Hu Y, Antoshechkin I, Miller MM, Sternberg PW, Aroian RV.
2015. The genome and transcriptome of the zoonotic hookworm Ancy-
lostoma ceylanicum identify infection-speciﬁc gene families. Nat Genet
47:416–422. https://doi.org/10.1038/ng.3237.
69. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and
memory-efﬁcient alignment of short DNA sequences to the human
genome. Genome Biol 10:R25. https://doi.org/10.1186/gb-2009-10-3-r25.
70. Li B, Dewey CN. 2011. RSEM: accurate transcript quantiﬁcation from
RNA-Seq data with or without a reference genome. BMC Bioinformatics
12:323. https://doi.org/10.1186/1471-2105-12-323.
71. National Institutes of Health. 2015. Public Health Service policy on
humane care and use of laboratory animals. Ofﬁce of Laboratory Animal
Welfare, National Institutes of Health, Bethesda, MD.
Batugedara et al. Infection and Immunity
November 2018 Volume 86 Issue 11 e00441-18 iai.asm.org 16
